Lowe syndrome: questions and answers


What is Lowe syndrome?
Lowe syndrome, also called oculocerebrorenal syndrome of Lowe, is a rare genetic disease that affects the eyes, the brain and the kidneys. Children are born with cataracts, have low muscle tone and delayed development, and develop kidney problems that can progress to kidney failure.

What are the symptoms of Lowe syndrome?
Lowe syndrome affects three parts of the body. Eyes: babies are born with cataracts in both eyes, and about half develop glaucoma. Brain and muscles: low muscle tone, delayed development and, in most, some degree of intellectual disability. Kidneys: the kidney tubules lose salts, minerals and proteins into the urine, and kidney function declines over the years.

What causes Lowe syndrome?
It is caused by changes in a single gene, OCRL, which sits on the X chromosome. That is why the disease almost always affects boys.

How is Lowe syndrome inherited?
A mother who carries a change in the OCRL gene can pass it on, and because boys have only one X chromosome the disease almost always affects boys. In about one in three boys the change is new and was not inherited.

How is Lowe syndrome diagnosed?
Doctors suspect Lowe syndrome in a baby boy with cataracts in both eyes, low muscle tone and signs of kidney tubule problems. A genetic test showing a change in the OCRL gene confirms the diagnosis.

How common is Lowe syndrome?
It is estimated to affect about 1 in 500,000 people.

Is there a treatment or a cure?
There is no approved treatment that addresses the cause of the disease. Today’s care treats the symptoms, for example eye surgery, physiotherapy and supportive kidney care.

Is there a gene therapy for Lowe syndrome?
Not yet. A gene therapy for the kidney is in development at Walther Therapeutics, the company founded and owned by Cure Lowe Foundation. It has not yet been tested in people. Read about our research

What is Cure Lowe Foundation?
Cure Lowe Foundation is a Danish non-profit based in Copenhagen, founded by Sebastian Honoré and Cecilie Bech Hammer after their son Walther was diagnosed with Lowe syndrome. It exists to develop treatments for Lowe syndrome and to make sure they reach the people who need them.

What is the foundation working on?
Three programmes: a gene therapy for the kidney, now in development at Walther Therapeutics; early research into a stem-cell gene therapy; and a search for existing medicines that might help sooner. Read about our research

What is Walther Therapeutics?
Walther Therapeutics is the drug development company founded and owned by Cure Lowe Foundation and named after Walther. It develops the kidney gene therapy for Lowe syndrome and the closely related Dent disease type 2. In August 2026 the US Food and Drug Administration granted the programme Rare Pediatric Disease Designation for both diseases. Visit walthertx.com

What is Dent disease type 2?
Dent disease type 2 is a kidney disease caused by changes in the same gene, OCRL. It mainly affects the kidneys, and some researchers consider it a mild form of Lowe syndrome. Read about Dent disease type 2

How is the foundation funded?
By donations from individuals and companies, by events such as the annual charity dinner, and by grants.

How can I get in touch?
Write to us through the contact page. Contact us

About us